James Gale - Net Worth and Insider Trading
James Gale Net Worth
The estimated net worth of James Gale is at least $298,768 dollars as of 2024-09-24. James Gale is the Director of Knight Therapeutics Inc and owns about 50,553 shares of Knight Therapeutics Inc (TSX:GUD) stock worth over $298,768. Details can be seen in James Gale's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James Gale has not made any transactions after 2021-01-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James Gale
James Gale Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James Gale owns 1 companies in total, including Knight Therapeutics Inc (TSX:GUD) .
Click here to see the complete history of James Gale’s form 4 insider trades.
Insider Ownership Summary of James Gale
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:GUD | Knight Therapeutics Inc | 2021-01-14 | Director |
James Gale Latest Holdings Summary
James Gale currently owns a total of 1 stock. James Gale owns 50,553 shares of Knight Therapeutics Inc (TSX:GUD) as of January 14, 2021, with a value of $298,768.
Latest Holdings of James Gale
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:GUD | Knight Therapeutics Inc | 2021-01-14 | 50,553 | 5.91 | 298,768 |
Holding Weightings of James Gale
James Gale Form 4 Trading Tracker
According to the SEC Form 4 filings, James Gale has made a total of 2 transactions in Knight Therapeutics Inc (TSX:GUD) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Knight Therapeutics Inc is the acquisition of 4,500 shares on January 14, 2021, which cost James Gale around $23,715.
Insider Trading History of James Gale
- 1
James Gale Trading Performance
GuruFocus tracks the stock performance after each of James Gale's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James Gale is -0.74%. GuruFocus also compares James Gale's trading performance to market benchmark return within the same time period. The performance of stocks bought by James Gale within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James Gale's insider trading performs compared to the benchmark.
Performance of James Gale
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.65 | | | | | |
| Relative Return to S&P 500(%) | 0.98 | | | | | |
James Gale Ownership Network
James Gale Owned Company Details
What does Knight Therapeutics Inc do?
Who are the key executives at Knight Therapeutics Inc?
James Gale is the Director of Knight Therapeutics Inc. Other key executives at Knight Therapeutics Inc include Senior Officer Amal Khouri , Director & Director or Senior Officer of 10% Security Holder Jonathan Ross Goodman , and 10% Security Holder Sime Armoyan .
Knight Therapeutics Inc (TSX:GUD) Insider Trades Summary
Over the past 18 months, James Gale made no insider transaction in Knight Therapeutics Inc (TSX:GUD). Other recent insider transactions involving Knight Therapeutics Inc (TSX:GUD) include a net purchase of 1,479,900 shares made by Sime Armoyan , a net sale of 65,000 shares made by Amal Khouri , and a net sale of 45,000 shares made by Robert Nathaniel Lande .
In summary, during the past 3 months, insiders sold 45,000 shares of Knight Therapeutics Inc (TSX:GUD) in total and bought 0 shares, with a net sale of 45,000 shares. During the past 18 months, 314,200 shares of Knight Therapeutics Inc (TSX:GUD) were sold and 1,734,100 shares were bought by its insiders, resulting in a net purchase of 1,419,900 shares.
Knight Therapeutics Inc (TSX:GUD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Knight Therapeutics Inc Insider Transactions
James Gale Mailing Address
Above is the net worth, insider trading, and ownership report for James Gale. Currently GuruFocus does not have mailing address information for James Gale.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
